Skip to main content

Renaissance Group LLC

SEC CIK
0000944234
Latest filing
Aug 13, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Renaissance Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
447,242
Value
$35.0M
% of portfolio
1.4%
Quarters held
4
Since Q3 2025
Holdings of HALO by Renaissance Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026447,242$35.0M1.4%−24,257−5.1%ReducedHolders
Q1 2026471,499$30.5M1.3%−9,653−2.0%ReducedHolders
Q4 2025481,152$32.4M1.3%+2,417+0.5%AddedHolders
Q3 2025478,735$35.1M1.3%+478,735NewHolders